HYPERTENSION DIAGNOSTICS, INC. Hypertension Diagnostics, Inc. Stock
Equities
HDII
US44914V1044
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.00% |
|
0.00% | -99.90% |
| 2019 | Hypertension Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2017 | CI |
| 2013 | Hypertension Diagnostics, Inc. Announces Resignation of Alan Stern as Director | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Financials (USD)
| Sales 2017 | 3.68M | Sales 2018 | 3.79M | Capitalization | 92.08K |
|---|---|---|---|---|---|
| Net income 2017 | - | Net income 2018 | - | EV / Sales 2017 | 1.15 x |
| Net Debt 2017 | 4.13M | Net Debt 2018 | 4.6M | EV / Sales 2018 | 1.24 x |
| P/E ratio 2017 |
-0.28
x | P/E ratio 2018 |
-0.54
x | Employees | - |
| Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
| 1 day | -99.00% |
1 month
0.00
0.00
Current year
0.000.00
1 year
0.000.00
3 years
0.000.03
5 years
0.000.21
10 years
0.000.21
| Managers | Title | Age | Since |
|---|---|---|---|
Liangjian Peng
CEO | Chief Executive Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Liangjian Peng
CEO | Chief Executive Officer | - | - |
Hypertension Diagnostics, Inc. is a shell company. The Company, through its subsidiary, China Specialty International Limited, focuses on brand licensing, distribution authorization and investment related to these registered brands and trademarks in provincial-level, city-level, country-level administrative regions in China.
| 1st Jan change | Capi. | |
|---|---|---|
| -99.90% | 284 | |
| +12.15% | 227B | |
| +14.90% | 197B | |
| +18.22% | 141B | |
| +29.15% | 110B | |
| +0.53% | 64.15B | |
| +16.92% | 53.72B | |
| +6.33% | 51.75B | |
| +10.93% | 45.2B | |
| +5.87% | 37.37B |
- Stock Market
- Equities
- HDII Stock